New Perspectives in Cytomegalovirus After Transplant: The Role of Immunosuppressant Management

Ligia C Pierrotti¹, Wanessa T Clemente^{2

3}

Affiliations

¹ Infectious Diseases Division, Hospital das Clinicas, Universidade de São Paulo, São Paulo, Brazil.
² Department of Laboratory Medicine, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
³ Liver Transplant Program-Transplant Infectious Diseases. Hospital das Clínicas EBSERH/UFMG, Belo Horizonte, Brazil.

Comment

Ligia C Pierrotti et al. Transplantation. 2023.

. 2023 Aug 1;107(8):1669-1670.

doi: 10.1097/TP.0000000000004560. Epub 2023 Apr 13.

Ligia C Pierrotti¹, Wanessa T Clemente^{2

3}

¹ Infectious Diseases Division, Hospital das Clinicas, Universidade de São Paulo, São Paulo, Brazil.
² Department of Laboratory Medicine, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
³ Liver Transplant Program-Transplant Infectious Diseases. Hospital das Clínicas EBSERH/UFMG, Belo Horizonte, Brazil.

No abstract available

Comment on

Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial.
Viana LA, Cristelli MP, Basso G, Santos DW, Dantas MTC, Dreige YC, Requião Moura LR, Nakamura MR, Medina-Pestana J, Tedesco-Silva H. Viana LA, et al. Transplantation. 2023 Aug 1;107(8):1835-1845. doi: 10.1097/TP.0000000000004559. Epub 2023 Jul 20. Transplantation. 2023. PMID: 37046380 Clinical Trial.

1. Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13512.
1. Arthurs SK, Eid AJ, Pedersen RA, et al. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis. 2008;46:840–846.
1. Santos CAQ, Brennan DC, Fraser VJ, et al. Delayed-onset cytomegalovirus disease coded during hospital readmission after kidney transplantation. Transplantation. 2014;98:187–194.
1. Bowman LJ, Brueckner AJ, Doligalski CT. The role of mTOR inhibitors in the management of viral infections. Transplantation. 2018;102:S50–S59.
1. Tedesco-Silva H, Felipe C, Ferreira A, et al. Reduced incidence of cytomegalovirus infection in kidney transplant recipients receiving everolimus and reduced tacrolimus doses. Am J Transplant. 2015;15:2655–2664.